INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following a Hunterbrook short report alleging inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations claim patients have suffered and died as a result of the company's practices. Ensign Group's stock fell 8.15% ($13.88 per share) to $156.42 on June 8, 2026, following the report's publication.